Document Detail


Cardiovascular risk and thiazolidinediones--what do meta-analyses really tell us?
MedLine Citation:
PMID:  20977573     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Meta-analyses of clinical trials suggest that the use of the thiazolidinedione (TZD), rosiglitazone, in patients with type 2 diabetes mellitus may increase the risk of myocardial ischaemic events by 30-40%. Although these controversial data must be interpreted with caution, in the absence of definitive prospective cardiovascular (CV) outcomes data, they represent a prominent source of evidence concerning the CV safety of rosiglitazone. The results of meta-analyses and a large randomized-controlled CV outcomes trial provide strong evidence that pioglitazone does not increase the risk of coronary events. This article clarifies the clinical significance of these meta-analytical findings alongside other sources of evidence and assesses their impact on evolving treatment guidelines and recommendations for the use of TZDs in patients with type 2 diabetes.
Authors:
G Schernthaner; R J Chilton
Related Documents :
17182793 - Plasma triacylglycerol and coagulation factor concentrations predict the anticoagulant ...
11393553 - Update on major trials for the prevention of type 1 diabetes mellitus: the american dia...
17445543 - Regression of acanthosis nigricans correlates with disappearance of anti-insulin recept...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Diabetes, obesity & metabolism     Volume:  12     ISSN:  1463-1326     ISO Abbreviation:  Diabetes Obes Metab     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-10-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883645     Medline TA:  Diabetes Obes Metab     Country:  England    
Other Details:
Languages:  eng     Pagination:  1023-35     Citation Subset:  IM    
Copyright Information:
© 2010 Blackwell Publishing Ltd.
Affiliation:
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria. guntram.schernthaner@wienkav.at
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Culture-independent characterization of a novel, uncultivated magnetotactic member of the Nitrospira...
Next Document:  The role of peroxisome proliferator-activated receptor ? in pancreatic ? cell function and survival:...